menu search

Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock

Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced the pricing of its underwritten public offering of approximately 24,228,719 shares of its common stock for gross proceeds of approximately $15.7 million, before deducting the underwriting discounts and commissions and other estimated offering […] The post Alaunos Therapeutics Announces Pricing of Public Offering... Read More
Posted: Nov 29 2022, 14:01
Author Name: forextv
Views: 102454

Search within

Pages Search Results: